Evaluating the Safety and Efficacy of Fixed-dose Once-weekly Oral Aripiprazole in Children and Adolescents with Touretteâ??s Disorder
Phase 3
- Conditions
- Health Condition 1: null- Children and Adolescents with Touretteâ??s Disorder
Recruitment & Eligibility
- Status
- Other (Terminated)
- Sex
- Not specified
- Target Recruitment
- 192
Inclusion Criteria
The subject is a male or female child or adolescent, 7 to 17 years of age (inclusive) at the time of signing the informed consent/assent.
Exclusion Criteria
The subject presents with a clinical presentation and/or history that is consistent with another
neurologic condition that may have accompanying abnormal movements.
These include, but are not limited to, the following:
• Transient Tic disorder
• Huntingtons disease
• Parkinsons disease
• Sydenhams chorea
• Wilsons disease
• Mental retardation
• Pervasive developmental disorder
• Traumatic brain injury
• Stroke
• Restless Legs Syndrome
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method